Concepedia

Mark M. T. J. Broekman

MM

Statistics

Publications

4

Citations

94

H-Index

4

Active since

2015

Affiliations

Radboud University Nijmegen(Current)

Radboud University Medical Center

Zuyderland Medisch Centrum

Radboud Institute for Molecular Life Sciences

Utrecht University

Mark M. T. J. Broekman is an author at Radboud University Nijmegen specializing in pharmacology, pharmacogenetics, and gastrointestinal pharmacology.

Publications per year

2015–2017

4

Publications

4

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Mark M. T. J. Broekman, Marieke J. H. Coenen, Corine J. van Marrewijk et al. · Inflammatory Bowel Diseases · 2017 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia

M. W. Hess, Jeroen H. F. de Baaij, Mark M. T. J. Broekman et al. · Pharmacogenetics and Genomics · 2016 · 32 citations

Life Sciences, Genetics, Pharmacology +17

Patients’ beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases

Mark M. T. J. Broekman, Marieke J. H. Coenen, Geert Wanten et al. · European Journal of Gastroenterology & Hepatology · 2017 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro

Mark M. T. J. Broekman, Hennie M.J. Roelofs, Dennis R. Wong et al. · Cell Biology and Toxicology · 2015 · 14 citations · Full text

Pharmacy, Pharmacology, Toxicology +16

1–4 of 4